Neymotin, A., Petri, S., Calingasan, N. Y., Wille, E., Schafer, P., Stewart, C., . . . Kiaei, M. (2009). Lenalidomide (Revlimid(®)) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.
Citação norma ChicagoNeymotin, Arie, Susanne Petri, Noel Y. Calingasan, Elizabeth Wille, Peter Schafer, Charles Stewart, Kenneth Hensley, M. Flint Beal, and Mahmoud Kiaei. Lenalidomide (Revlimid(®)) Administration At Symptom Onset Is Neuroprotective in a Mouse Model of Amyotrophic Lateral Sclerosis. 2009.
Citação norma MLANeymotin, Arie, et al. Lenalidomide (Revlimid(®)) Administration At Symptom Onset Is Neuroprotective in a Mouse Model of Amyotrophic Lateral Sclerosis. 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.